secwatch.observer — SEC 8-K summary
======================================

Issuer:     Renalytix plc (RNLXY)
CIK:        0001811115
Form:       8-K
Filed at:   2024-04-26T23:59:59+00:00
Accession:  0000950170-24-048658
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Renalytix closes second tranche of private placement, raises ~$7M gross
-----------------------------------------------------------------------

- Second Tranche of 26,815,841 ordinary shares at £0.20 each closed on April 24, 2024, following shareholder approval.
- Gross proceeds from Second Tranche ~$7M; net proceeds expected to extend cash runway into calendar Q4 2024.
- Post-issuance total ordinary shares outstanding: 154,368,191.
- Company to file resale registration statement with SEC within 45 days of Second Closing.
- First Tranche of 19,986,031 shares closed March 14, 2024; combined offering proceeds extend runway.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1811115/000095017024048658/0000950170-24-048658-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1811115/000095017024048658/rnlx-20240424.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-048658

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer